Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,326 | 629 | 97.1% |
| Travel and Lodging | $380.71 | 5 | 2.6% |
| Education | $46.67 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,545 | 175 | $0 (2024) |
| Amgen Inc. | $1,385 | 50 | $0 (2024) |
| Amarin Pharma Inc. | $1,303 | 58 | $0 (2023) |
| Novo Nordisk Inc | $1,105 | 41 | $0 (2024) |
| Apyx Medical Corporation | $1,030 | 16 | $0 (2020) |
| Merck Sharp & Dohme LLC | $645.34 | 31 | $0 (2023) |
| Lilly USA, LLC | $606.73 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $572.04 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $515.65 | 29 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $464.47 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,159 | 73 | AstraZeneca Pharmaceuticals LP ($791.10) |
| 2023 | $1,872 | 81 | AstraZeneca Pharmaceuticals LP ($421.50) |
| 2022 | $2,046 | 81 | AstraZeneca Pharmaceuticals LP ($429.79) |
| 2021 | $1,661 | 88 | Amarin Pharma Inc. ($301.28) |
| 2020 | $1,314 | 67 | AstraZeneca Pharmaceuticals LP ($426.49) |
| 2019 | $1,677 | 73 | AstraZeneca Pharmaceuticals LP ($330.77) |
| 2018 | $2,615 | 98 | Apyx Medical Corporation ($671.24) |
| 2017 | $1,409 | 79 | AstraZeneca Pharmaceuticals LP ($345.20) |
All Payment Transactions
640 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: UROLOGY | ||||||
| 11/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Obesity | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: VACCINES | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $48.46 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $117.77 | General |
| Category: Obesity | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 938 | 1,613 | $181,415 | $108,646 |
| 2022 | 11 | 1,066 | 1,801 | $197,565 | $122,881 |
| 2021 | 14 | 1,156 | 1,939 | $196,660 | $121,876 |
| 2020 | 13 | 1,088 | 1,963 | $199,975 | $95,792 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 201 | 611 | $76,375 | $48,278 | 63.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 250 | $50,100 | $27,546 | 55.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $11,520 | $9,531 | 82.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 90 | 168 | $15,120 | $8,019 | 53.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 42 | $12,600 | $6,812 | 54.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 160 | 251 | $3,765 | $2,108 | 56.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 73 | 73 | $2,920 | $1,574 | 53.9% |
| 11980 | Placement of hormone pellet under skin | Office | 2023 | 13 | 17 | $2,550 | $1,502 | 58.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 66 | 66 | $1,980 | $1,423 | 71.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $1,055 | $791.56 | 75.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $600.00 | $588.00 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 37 | $2,830 | $472.15 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 199 | 661 | $82,625 | $52,929 | 64.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 250 | $50,000 | $28,840 | 57.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 109 | 109 | $19,620 | $16,984 | 86.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 119 | 190 | $17,100 | $9,331 | 54.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 35 | $10,500 | $6,134 | 58.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 117 | 117 | $4,680 | $2,654 | 56.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 118 | 118 | $3,540 | $2,627 | 74.2% |
| 11980 | Placement of hormone pellet under skin | Office | 2022 | 12 | 19 | $2,850 | $1,658 | 58.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 163 | 258 | $3,870 | $763.98 | 19.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 17 | $890.00 | $601.73 | 67.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 25 | 27 | $1,890 | $358.29 | 19.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 186 | 521 | $65,125 | $44,337 | 68.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 262 | $52,400 | $29,885 | 57.0% |
About Dr. Paul Leva, MD
Dr. Paul Leva, MD is a Internal Medicine healthcare provider based in Northport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841222577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Leva, MD has received a total of $14,754 in payments from pharmaceutical and medical device companies, with $2,159 received in 2024. These payments were reported across 640 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($14,326).
As a Medicare-enrolled provider, Leva has provided services to 4,248 Medicare beneficiaries, totaling 7,316 services with total Medicare billing of $449,194. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Northport, NY
- Active Since 07/06/2006
- Last Updated 12/17/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841222577
Products in Payments
- FARXIGA (Drug) $2,299
- Vascepa (Drug) $1,303
- Otezla (Drug) $555.60
- XARELTO (Drug) $554.44
- Repatha (Biological) $499.42
- TRELEGY ELLIPTA (Drug) $486.23
- GEMTESA (Drug) $464.47
- BREZTRI (Drug) $435.41
- Wegovy (Drug) $433.21
- AIRSUPRA (Drug) $420.94
- Livalo (Drug) $269.79
- SYMBICORT (Drug) $247.75
- JANUVIA (Drug) $239.02
- Ozempic (Drug) $233.08
- General - Pain Management (Device) $205.67
- Rybelsus (Drug) $200.71
- TRULICITY (Drug) $167.98
- Xeomin (Biological) $158.29
- Dayvigo (Drug) $157.60
- LEQVIO (Drug) $151.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Northport
Dr. Stephen Browne, M.d, M.D
Internal Medicine — Payments: $20,215
Brittany Hill, Do, DO
Internal Medicine — Payments: $16,519
Ginny Leva, Md, MD
Internal Medicine — Payments: $8,840
Mr. Roger Perrone, M.d, M.D
Internal Medicine — Payments: $1,748
Dr. Richard Boughal, Md, MD
Internal Medicine — Payments: $756.92
Dr. Hillary Diamond, M.d, M.D
Internal Medicine — Payments: $601.48